SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019910
Filing Date
2023-12-19
Accepted
2023-12-19 16:05:51
Documents
99
Period of Report
2023-12-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nhwk-20231219x8k.htm   iXBRL 8-K 204346
2 EX-23.1 nhwk-20231219xex23d1.htm EX-23.1 2510
3 EX-99.1 nhwk-20231219xex99d1.htm   iXBRL EX-99.1 2107109
  Complete submission text file 0001558370-23-019910.txt   13638643

Data Files

Seq Description Document Type Size
4 EX-101.SCH nhwk-20231219.xsd EX-101.SCH 99417
5 EX-101.CAL nhwk-20231219_cal.xml EX-101.CAL 122723
6 EX-101.DEF nhwk-20231219_def.xml EX-101.DEF 398055
7 EX-101.LAB nhwk-20231219_lab.xml EX-101.LAB 875700
8 EX-101.PRE nhwk-20231219_pre.xml EX-101.PRE 702211
93 EXTRACTED XBRL INSTANCE DOCUMENT nhwk-20231219x8k_htm.xml XML 2824457
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
NightHawk Biosciences, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 231497310
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)